Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

*Product:*	Rinvoq
Active Ingredient:	Upadacitinib hemihydrate 15.4mg equivalent to upadacitinib 15mg
Dosage Form:	Modified release tablet
New Zealand Sponsor:	AbbVie Limited
Manufacturer:	AbbVie Ireland NL B.V., Sligo, Ireland

*Product:*	Rinvoq
Active Ingredient:	Upadacitinib hemihydrate 30.7mg equivalent to upadacitinib 30mg
Dosage Form:	Modified release tablet
New Zealand Sponsor:	AbbVie Limited
Manufacturer:	AbbVie Ireland NL B.V., Sligo, Ireland

Dated this 14th day of October 2024.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).

Tags

Notice Number

Schedule